We are live on ! Find out more
OCUL icon

Ocular Therapeutix
OCUL

216 hedge funds and large institutions have $2.2B invested in Ocular Therapeutix in 2025 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 72 increasing their positions, 58 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 18

105% more call options, than puts

Call options by funds: $22M | Put options by funds: $10.7M

51% more capital invested

Capital invested by funds: $1.45B → $2.2B (+$746M)

24% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 58

16% more funds holding

Funds holding: 186 → 216 (+30)

10% more funds holding in top 10

Funds holding in top 10: 10 → 11 (+1)

9.56% more ownership

Funds ownership: 98.59% → 108.15% (+9.6%)

Holders
216
Holders Change
+30
Holders Change %
+16.13%
% of All Funds
2.83%
Holding in Top 10
11
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+10%
% of All Funds
0.14%
New
51
Increased
72
Reduced
58
Closed
18
Calls
$22M
Puts
$10.7M
Net Calls
+$11.2M
Net Calls Change
+$5.65M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$146M
2
Millennium Management
Millennium Management
New York
+$44.7M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$39M
4
ACA
Avoro Capital Advisors
New York
+$34.1M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$32.3M

Top Sellers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
-$28.2M
2
SR
Summer Road
Florida
-$15.6M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$13.7M
4
Franklin Resources
Franklin Resources
California
-$10.9M
5
RA
Rosalind Advisors
Ontario, Canada
-$9.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
RA
51
Rosalind Advisors
Ontario, Canada
$4.68M -$9.79M -818,700 -67%
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$4.62M +$45K +3,765 +1%
EIM
53
Essex Investment Management
Massachusetts
$4.61M +$149K +12,481 +3%
SC
54
Stempoint Capital
New York
$4.2M +$4.3M +359,470 New
Jane Street
55
Jane Street
New York
$4.14M +$2.91M +243,340 +220%
Squarepoint
56
Squarepoint
New York
$4.1M +$4.19M +350,758 New
N
57
Nuveen
North Carolina
$4.04M -$203K -16,949 -5%
First Trust Advisors
58
First Trust Advisors
Illinois
$3.97M +$4.06M +339,631 New
HF
59
HRT Financial
New York
$3.77M +$3.86M +322,914 New
Deutsche Bank
60
Deutsche Bank
Germany
$3.65M +$862K +72,061 +30%
RSCM
61
Rock Springs Capital Management
Maryland
$3.51M +$3.59M +300,000 New
JP Morgan Chase
62
JP Morgan Chase
New York
$3.23M -$5.21M -435,940 -61%
EAM
63
Erste Asset Management
Austria
$2.95M – – –
ELI
64
Empire Life Investments
Ontario, Canada
$2.94M +$3M +251,262 New
CC
65
Centiva Capital
New York
$2.92M +$2.99M +250,000 New
AAA
66
Affinity Asset Advisors
New York
$2.79M +$2.86M +239,000 New
Two Sigma Investments
67
Two Sigma Investments
New York
$2.74M +$1.48M +123,381 +111%
RhumbLine Advisers
68
RhumbLine Advisers
Massachusetts
$2.57M -$66.2K -5,540 -2%
RPAM
69
Rhenman & Partners Asset Management
Sweden
$2.36M +$2.42M +202,000 New
CF
70
Cantor Fitzgerald
New York
$2.36M +$2.41M +201,865 New
UBS AM
71
UBS AM
Illinois
$2.35M -$1.38M -115,017 -36%
Swiss National Bank
72
Swiss National Bank
Switzerland
$2.35M +$39.5K +3,300 +2%
TI
73
Trexquant Investment
Connecticut
$2.2M +$2.25M +187,782 New
VOYA Investment Management
74
VOYA Investment Management
Georgia
$2.16M -$1.28M -107,143 -37%
RA
75
RoundAngle Advisors
New Jersey
$2.07M -$106K -8,906 -5%
1 2
3
4 5

OCUL Hedge Fund Activity: Q3 2025 in Review

216 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Ocular Therapeutix (OCUL) for Q3 2025, worth a combined $2.2B — up 51% from $1.45B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new OCUL positions and 18 closed out — a net gain of 33 holders — while 72 added to existing stakes and 58 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $146M. The largest seller was Deep Track Capital, cutting an estimated $28.2M.

  • 216 institutional investors held Ocular Therapeutix (OCUL) as of Q3 2025, up from 186 in Q2 2025.
  • Funds reported $2.2B of Ocular Therapeutix stock for Q3 2025, up 51% quarter-over-quarter.
  • 51 funds opened new Ocular Therapeutix positions in Q3 2025 and 18 closed out, a net change of +33 holders.
  • The largest Ocular Therapeutix buyer in Q3 2025 was Fidelity Investments, an estimated $146M added.
  • The largest Ocular Therapeutix seller in Q3 2025 was Deep Track Capital, an estimated $28.2M sold.

Based on aggregated 13F filings for Q3 2025.